Literature DB >> 30011259

Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk.

John Sg Wells1, Michael Bergin, Marie-Claire Van Hout, Pádraig McGuinness, Jaco De Pleissisc, Eileen Rich, Siphokazi Dada, Richard Wells, Martina Ann Gooney.   

Abstract

PURPOSE: Codeine containing medicines can carry a number of health risks associated with the increase in reported misuse and dependence, however they are still readily available over the counter (OTC) in many countries. The aim of this novel study was to report on the results of a survey of customers purchasing OTC codeine containing medicinal products at pharmacies in Ireland, South Africa and England; exploring use, sources of knowledge and perception of risks.
METHODS: The study design was an exploratory cross sectional survey. It involved a customer self-administered questionnaire at the point of purchase (n=1230).  Relationships between categorical variables were analysed using Pearson chi-square for bivariate analysis. Continuous scale variables were analysed using one way analysis of variance.
RESULTS: In Ireland 6% stated they purchased codeine containing products weekly, in South Africa 13% and in England 16%. In Ireland and England women are more likely to view codeine containing products as harmful. In England older adults are more likely to perceive codeine containing products as harmful. A higher proportion of customers in South Africa opposed restricting codeine containing products to prescription only when compared with people in Ireland and England.
CONCLUSIONS: Codeine containing products are widely purchased and used in all three jurisdictions. Whilst the majority of customers appear to have some awareness and knowledge of risks, it does not materially impact on their purchasing behaviour with a substantial minority purchasing/using such products on a weekly basis. This regularity of purchase whilst indicative of the popularity of such products, may also be a potential indicator of misuse. Future research is needed in relation to cultural and gendered differences and targeted information giving and harm reduction initiatives for safe usage of these medicinal products.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30011259     DOI: 10.18433/jpps30049

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  6 in total

1.  Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa.

Authors:  Buyisile Chibi; Nonhlanhla Yende-Zuma; Tivani P Mashamba-Thompson
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

2.  The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.

Authors:  Charlotte G Boone; Tony Antoniou; David N Juurlink; Teagan Rolf von den Baumen; Sophie A Kitchen; Georgia C Richards; Mina Tadrous; Tara Gomes
Journal:  CMAJ Open       Date:  2021-12-14

3.  'I Was Present but I Was Absent': Perceptions and Experiences of the Non-Medical Use of Prescription or over the Counter Medication among Employed South African Women.

Authors:  Nadine Harker; Jodilee Erasmus; Warren Lucas; Diane Deitz; Carrie Brooke-Sumner
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

4.  Nationwide Population-Based Study About Patterns of Prescription Opioid Use and Misuse Among Young Adults in Spain.

Authors:  Pilar Carrasco-Garrido; Carmen Gallardo-Pino; Isabel Jiménez-Trujillo; Valentín Hernández-Barrera; Soledad García-Gómez-Heras; Lidiane Lima Florencio; Domingo Palacios-Ceña
Journal:  Int J Public Health       Date:  2022-08-19       Impact factor: 5.100

Review 5.  Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.

Authors:  Łukasz Sobczak; Krzysztof Goryński
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

6.  Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Authors:  Stefania Chiappini; Fabrizio Schifano; John Martin Corkery; Amira Guirguis
Journal:  J Psychopharmacol       Date:  2021-01-10       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.